DSIP 5mg
DSIP (Delta Sleep-Inducing Peptide) 5mg is a naturally occurring neuropeptide isolated from the central nervous system. Research focuses on its role as a neuromodulator that influences sleep architecture, stress-response pathways, and endocrine function without acting as a direct sedative.
Specifications
| Name | DSIP (Delta Sleep-Inducing Peptide) |
| Type | Research Peptide: Neuromodulator |
| Amino Acid Count | 9 |
| Purity | ± 99% (HPLC – COA available) |
| Molecular Weight | 848.81 g/mol |
| Analysis | HPLC, MS |
| Form | Lyophilized powder |
| Storage Conditions | 2-8°C (short-term) or -20°C (long-term) |
Confidential Lab Data - Specification Sheet
C35H48N10O15
Scientific History
DSIP (Delta Sleep-Inducing Peptide) was first isolated in 1977 by a Swiss research group led by Guido Schoenenberger. The peptide was extracted from the cerebral venous blood of rabbits during induced slow-wave (delta) sleep states.
Initial research aimed to uncover endogenous sleep-regulating factors. Subsequent studies demonstrated that DSIP was not merely a sleep promoter, but rather a regulatory peptide involved in circadian rhythm modulation, stress response regulation, and endocrine secretion balance.
Mechanism of Action
DSIP operates as a complex neuromodulator within the central nervous system. Rather than directly binding to a single receptor type like traditional sedatives, it modulates neurotransmitter activity and reduces basal ACTH levels. This leads to the normalization of sleep architecture—specifically promoting slow-wave delta sleep—and helps stabilize physiological stress pathways.